Improvements in or relating to organic compounds

JP2022546957A5Active Publication Date: 2024-11-14GIVAUDAN SA
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
JP2022513075
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2019-08-29
Filing Date
2020-08-21
Publication Date
2024-11-14
Estimated Expiration
2040-08-21

AI Technical Summary

Technical Problem

Existing encapsulated microcapsules for benefit agents in consumer products, such as hair care, suffer from poor deposition and adhesion on keratinous surfaces when exposed to drying with a hair dryer, leading to reduced performance and stability.

Method used

The use of a core-shell microcapsule composition comprising a core containing a benefit agent, a shell formed by a polyurea resin reaction of trifunctional isocyanate and multifunctional amine, with chitosan, and optionally water-dispersible polyisocyanate, to enhance adhesion and deposition on hair surfaces.

Benefits of technology

The composition achieves improved deposition and adhesion of microcapsules on hair even after drying with a hair dryer, maintaining benefit agent release characteristics and operational safety.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

An encapsulated composition comprising at least one core-shell microcapsule is described. The at least one core-shell microcapsule comprises a core containing at least one benefit agent and a shell surrounding the core. The shell comprises a polyurea resin formed by the reaction of at least one trifunctional isocyanate with at least one polyfunctional amine that is not chitosan. The at least one trifunctional isocyanate is an adduct of an aliphatic triol and at least one araliphatic diisocyanate. The weight ratio between the portion of the polyurea resin derived from the trifunctional isocyanate and the core is between 0.09 and 0.30, preferably between 0.10 and 0.20, and more preferably between 0.11 and 0.18. The shell further comprises chitosan. The present disclosure also relates to methods for preparing such encapsulated compositions and their use to enhance the performance of benefit agents in consumer products.
Need to check novelty before this filing date? Find Prior Art

Description

[Technical Field]

[0001] The present invention relates to encapsulated compositions comprising at least one core-shell microcapsule. The present invention also relates to methods for preparing such compositions and their use to enhance the performance of beneficial agents in consumer products. [Background technology]

[0002] It is known that encapsulated beneficial agents are incorporated into consumer products, such as household care, personal care, and fabric care products. Beneficial agents include, for example, fragrances, cosmetic agents, food ingredients, nutrients, drugs, and substrate enhancers.

[0003] Microcapsules specifically suitable for the delivery of such beneficial agents are core-shell microcapsules, wherein the core typically contains the beneficial agent, and the shell is impermeable to or partially impermeable to the beneficial agent. Generally, these microcapsules are employed in aqueous media, and the encapsulated beneficial agent is hydrophobic. A wide selection of shell materials can be used, provided that the shell material is impermeable to or partially impermeable to the encapsulated beneficial agent.

[0004] Beneficial agents are encapsulated for a variety of reasons. Microcapsules can separate and protect such materials from external suspension media, such as consumer product bases, where they may be incompatible or unstable. They are also used to aid in the deposition of beneficial agents onto substrates such as skin or hair, or, in the case of fragrance components, onto fabrics or hard household surfaces. They can also act as a means of controlling the spatiotemporal release of beneficial agents.

[0005] A variety of encapsulation media and beneficial agents suitable for the preparation of encapsulated compositions have been proposed in the prior art. Such encapsulation media include synthetic resins made from polyamides, polyureas, polyurethanes, polyacrylates, melamine-derived resins, or mixtures thereof.

[0006] In many cases, the deposition and adhesion of such microcapsules onto a smooth surface, and particularly onto a keratin surface such as skin and hair, are insufficient, and the expected benefits associated with the use of microcapsules are not optimal. This is particularly the case for rinse-off products that involve a large amount of water. In this case, the lack of deposition may be due to the dilution of the microcapsules. The large volume of rinse water can also wash away the microcapsules from the surface.

[0007] WO 2011 / 161229 A1 describes an encapsulated fragrance composition comprising core-shell microcapsules having a shell made of a polyurethane resin produced by the reaction of two structurally different isocyanates. These microcapsules show good deposition onto a keratin surface in a rinse-off application. However, it has been found that, particularly in hair care, the method of drying after rinsing can have a significant impact on the benefits provided by microcapsules. While good deposition and adhesion are generally observed with air drying, the use of a hair dryer has been found to result in reduced performance.

[0008] Therefore, it is an object inherent in the present invention to overcome the above-mentioned drawbacks of the prior art. In particular, it is an object inherent in the present invention to provide an encapsulated composition of the above type that shows improved deposition and adhesion onto hair after drying the hair with a hair dryer. These microcapsules should maintain their desired beneficial agent release characteristics during manufacture, storage, and application. Furthermore, the composition should be manufactured in an operationally safe, robust, and cost-effective process. Summary of the Invention

[0009] These problems are solved by the encapsulated compositions according to the present invention. Such compositions comprise at least one core-shell microcapsule. At least one core-shell microcapsule comprises a core comprising at least one beneficial agent and a shell surrounding the core. The shell comprises a polyurethane resin formed by the reaction of at least one trifunctional isocyanate and at least one polyfunctional amine other than chitosan. At least one trifunctional isocyanate is an adduct of an aliphatic triol and at least one aromatic aliphatic diisocyanate. The weight ratio between the part of the polyurethane resin derived from the trifunctional isocyanate and the core is between 0.09 and 0.30, preferably between 0.10 and 0.20, more preferably between 0.11 and 0.18. The shell further comprises chitosan.

[0010] In this context, the term "beneficial agent" refers to any substance that, when added to a product, can improve the perception of this product by the consumer or enhance the action of this product in its application. Typical beneficial agents include fragrance components, flavor components, cosmetic components, bioactive agents (such as bactericides, insect repellents and pheromones, etc.), substrate enhancers (such as silicones and brighteners, etc.), enzymes (such as lipase, and protease, etc.), dyes, pigments and nutraceuticals.

[0011] An organic isocyanate is a compound in which an isocyanate group is bonded to an organic residue (R-N=C=O or R-NCO). In the context of the present invention, a polyisocyanate (or polyfunctional isocyanate) is an organic isocyanate having two or more (by way of example, 3, 4, 5, etc.) isocyanate groups in the molecule. A trifunctional isocyanate is an isocyanate having 3 isocyanates in the molecule.

[0012] As is known in the art, chitosan is a biopolymer derived from chitin, which forms the exoskeleton of crustaceans and protects the shape of various fungi, such as Ascomycetes, Zygomycetes, Basidiomycetes, and Deuteromycetes, e.g., Absidia, Mucor, Aspergillus Niger, Ganoderma Lucidum, and Rhizopus Oryzae. Chitosan production is associated with the alkali or enzymatic deacetylation of chitin and is characterized by the degree of deacetylation. Both low deacetylation, typically less than 80% deacetylation, and high deacetylation, typically higher than or equal to 80% deacetylation, exist. Deacetylated chitosan is a copolymer consisting of N-acetyl-D-glucosamine and D-glucosamine moieties. The degree of deacetylation is, 1 H and / or 13 The molecular weight may be determined by 13C nuclear magnetic resonance spectroscopy. Chitosan is typically available with molecular weights ranging from 3,000 to 5,000,000 g / mol. The molecular weight may be determined by viscometery and / or gel permeation chromatography according to methods known in the art.

[0013] In the context of the present invention, “a polyfunctional amine that is not chitosan” refers to an amine comprising at least two groups capable of reacting with an NCO group, wherein at least one of the groups capable of reacting with an NCO group is a primary or secondary amino group. These amines are structurally not identical to chitosan. When the polyfunctional amine contains only one primary or secondary amino group, it will contain one or more additional functional groups capable of reacting with an NCO group in the polymerization reaction. The groups of the polyfunctional amine that are highly reactive with the NCO group are preferably selected from hydroxyl groups and primary or secondary amino groups. The reaction of the NCO group with the amino group leads to the formation of a urea group. The reaction of the NCO group with the OH group leads to the formation of a urethane group. However, the reaction with the OH group often requires a catalyst. The amount of polyfunctional amine introduced is usually in molar excess compared to the stoichiometric amount required to convert the free isocyanate group.

[0014] Generally, "aromatic aliphatic isocyanates or polyisocyanates" are compounds in which at least one isocyanate group is bonded to an aromatic residue via an alkyl residue, particularly a methylene residue. To avoid any ambiguity, “the shell further contains chitosan” does not necessarily mean that, strictly speaking, it does, while it may indeed be so, as will be further described below herein, that during encapsulation, the chitosan undergoes a reaction with other shell-forming materials, and in particular with at least one trifunctional isocyanate, to construct the polyurea resin. More specifically, the present invention also covers cases where the microcapsule shell includes, in example, a coating of chitosan, meaning that the chitosan is deposited on the shell. On the other hand, chitosan can also be encapsulated within the shell of the microcapsule.

[0015] In addressing the challenges of prior art, it was found that using a specific amount of at least one trifunctional isocyanate in combination with chitosan during the formation process of polyurea macrocapsule shells resulted in improved deposition and adhesion of capsules on hair after hair was dried with a hairdryer. The aliphatic triol can be selected from the group consisting of 2-ethylpropane-1,2,3-triol and 2-ethyl-2-(hydroxymethyl)propane-1,3-diol, preferably 2-ethylpropane-1,2,3-triol.

[0016] Preferably, at least one aromatic aliphatic diisocyanate is selected from the group consisting of 1,2-bis(isocyanatemethyl)benzene, 1,3-bis(isocyanatemethyl)benzene, 1,4-bis(isocyanatemethyl)benzene, 1-isocyanate-2-(isocyanatemethyl)benzene, 1-isocyanate-3-(isocyanatemethyl)benzene, and 1-isocyanate-4-(isocyanatemethyl)benzene.

[0017] This type of functional isocyanate is available under the trademarks Takenate D-110N (ex Mitsui) or Desmodur Quix 175 (ex Covestro). Such isocyanates have the advantage of being more reactive than aliphatic polyisocyanates and less reactive than aromatic polyisocyanates. While not bound by any theory, due to this intermediate reactivity, the polyurea resins formed during the polyaddition of aromatic aliphatic polyisocyanates and polyfunctional amines are more uniformly crosslinked than those obtained with aromatic polyisocyanates. On the other hand, the crosslinking is more efficient than that obtained with aliphatic polyisocyanates. In a specific embodiment of the present invention, the trifunctional isocyanate is an adduct of 2-ethylpropane-1,2,3-triol and 1,3-bis(isocyanatemethyl)benzene.

[0018] As previously mentioned, in a preferred embodiment of the present invention, the chitosan is deposited on the outer surface of the shell surrounding the core, and / or the chitosan is encapsulated within the shell surrounding the core. In this context, the composition may further contain free chitosan, as an adsorption / desorption equilibrium of chitosan may occur. In the context of the present invention, “free chitosan” is used to describe chitosan that is spatially separated from the “microcapsules” by the dispersion medium when the “microcapsules” are dispersed in the dispersion medium.

[0019] On the other hand, polyurea resins can also be formed by the reaction of at least one trifunctional isocyanate, at least one polyfunctional amine (other than chitosan), and chitosan. Not bound by any theory, the applicant believes that using chitosan as a reactive species in the formation of polyurea resins makes the resin more viscoelastic, which in turn promotes adhesion of the microcapsule shell to the substrate. In another preferred embodiment of the present invention, the polyurea resin is formed by the reaction of at least one trifunctional isocyanate and a water-dispersible polyisocyanate with at least one polyfunctional amine that is not chitosan, and optionally with chitosan.

[0020] In the context of the present invention, "water-dispersible polyisocyanate" refers to a polyisocyanate that can be dispersed in an aqueous medium in the form of finely divided solid particles or droplets. Suitable water-dispersible polyisocyanates are, in practice, aromatic, alicyclic, or aliphatic. Water-dispersible polyisocyanates are preferably anion-modified polyisocyanates. Anion-modified polyisocyanates contain at least two isocyanate groups and at least one functional group that is anionic or aniogenic. An "aniogenic functional group" is a group that can become anionic depending on the chemical environment, for example, pH. Suitable anionic or anionic groups include, for example, carboxylic acid groups, sulfonic acid groups, phosphonic acid groups, and their salts.

[0021] Anionically modified polyisocyanates may contain one or more sulfonic acid groups or salts thereof. Preferred salts may be sodium, potassium, or ammonium salts. Ammonium salts are preferred. Preferably, the anionically modified polyisocyanate is obtained by the reaction of a polyisocyanate with 2-(cyclohexylamino)-ethanesulfonic acid and / or 3-(cyclohexylamino)-propanesulfonic acid. More preferably, anionically modified polyisocyanates are obtained by the reaction of a polyisocyanate with 2-(cyclohexylamino)-ethanesulfonic acid and / or 3-(cyclohexylamino)-propanesulfonic acid, where the polyisocyanate is selected from hexamethylene diisocyanate, tetramethylene diisocyanate, isophorone diisocyanate, dicyclohexylmethane-4,4'-diisocyanate, 2,4- and 2,6-toluylene diisocyanates and mixtures thereof, diphenylmethane diisocyanate, biuret, allophanate and / or isocyanurates of the previously mentioned polyisocyanates.

[0022] The anion-modified polyisocyanates may, in each case, be selected from anion-modified hexamethylene diisocyanates, isophorone diisocyanates, dicyclohexylmethane-4,4'-diisocyanates, isocyanurates of hexamethylene diisocyanates, and mixtures thereof. Preferably, the anion-modified polyisocyanate has the following: - At least 1.8 average isocyanate functionality, - Isocyanate group content of 4.0-26.0 wt.-% (calculated as NCO: molecular weight = 42), - Sulfonate group content of 0.1~7.7 wt.-% (calculated as SO3; molecular weight = 80), and - Optionally, the content of ethylene oxide units bonded within a polyether chain of 0 to 19.5 wt (calculated as C2H2O; molecular weight = 44), where the polyether chain contains a statistical average of 5 to 55 ethylene oxide units.

[0023] In a preferred embodiment of the present invention, the water-dispersible polyisocyanate is a water-dispersible polyisosonate based on hexamethylene diisocyanate. More specifically, the anion-modified polyisosonate may be selected from anion-modified hexamethylene diisocyanate, anion-modified hexamethylene diisocyanate isocyanurate, and mixtures thereof.

[0024] In a particularly preferred embodiment, the anion-modified polyisocyanate is of formula (1) [ka] Follow the rules.

[0025] Formula (1) represents a commercially available anionically modified polyisocyanate, which is a hexamethylene diisocyanate-modified isocyanurate marketed by Covestro under the trademark Bayhydur XP2547. The weight ratio between the polyurea resin portion derived from the water-dispersible polyisocyanate and the core is between 0.001 and 0.2, preferably between 0.005 and 0.1, and more preferably between 0.01 and 0.05. The polyfunctional amines other than chitosan are preferably selected from diamines, triamines, tetramines, and higher-order polyfunctional amines, amino alcohols, melamines, ureas, hydrazines, polymerizable polyamines, and mixtures thereof.

[0026] Suitable diamines include, for example, 1,2-ethylenediamine, 1,3-propylenediamine, 1,4-diaminobutane, 1,5-diaminopentane, 1,6-diaminohexane, 1,3-diamino-1-methylpropane, 1,4-diaminocyclohexane, piperazine, or mixtures thereof. Suitable amino alcohols include, for example, 2-aminoethanol, 2-(N-methylamino)ethanol, 3-aminopropanol, 4-aminobutanol, 1-ethylaminobutan-2-ol, 2-amino-2-methyl-1-propanol, 4-methyl-4-aminopentan-2-ol, or mixtures thereof.

[0027] Suitable polymeric polyamines are, in principle, linear or branched polymers having at least two primary or secondary amino groups. In addition, these polymers may have tertiary amino groups in the polymer chain. The polymerizable polyamine is preferably selected from polyalkyleneamines, polyvinylamines, polyetheramines, and mixtures thereof. More preferably, the polymerizable polyamine is selected from poly(alkyleneimines), particularly poly(ethyleneimines). Polymeric polyamines having a weight-average molecular weight of at least 300 g / mol are preferred. Polymeric polyamines having a weight-average molecular weight of 500 to 2,000,000 g / mol, particularly 700 to 1,000,000 g / mol, and more specifically 800 to 500,000 g / mol are more preferred.

[0028] In a preferred embodiment, the polyfunctional amine other than chitosan is poly(ethyleneimine). Poly(ethyleneimine) has the general formula H2N(CH2CH2NH). nThese can be short-chain poly(ethyleneimines) containing hydrogen, where n is an integer > 1 (n=2: diethylenetriamine; n=3: triethylenetetramine; n=4: tetraethylenepentaamine). These are sometimes referred to as poly(ethyleneamine) or poly(alkylene polyamine). Poly(ethyleneimine) may also be a long-chain poly(ethyleneimine). In accordance with the present invention, poly(ethyleneimine) having a molecular weight of at least 500 g / mol, preferably 600 to 30,000 or 650 to 25,000 g / mol, and particularly 700 to 10,000 g / mol or 850 to 5,000 g / mol, is preferably used.

[0029] Polyfunctional amines are characterized by the following repeating units [ka] Here, - x is between 8 and 1,500, preferably between 10 and 1,000; - y is between 0 and 10, preferably between 0 and 5, especially 0; - z is 2 + y. It may be a poly(ethyleneimine) containing this material.

[0030] These poly(ethyleneimines) can be used to achieve good results, particularly regarding leakage in the extraction medium. The preferred poly(ethyleneimine) is linear poly(ethyleneimine) where x is between 8 and 1500, y is 0, and z is 2. A preferred commercially available poly(ethyleneimine) is sold by BASF SE under the trademark Lupasol, specifically Lupasol G100.

[0031] The weight ratio between the polyurea resin portion derived from the polyfunctional amine and the core may be between 0.01 and 0.1, preferably between 0.015 and 0.05, and more preferably between 0.018 and 0.025. In a preferred embodiment of the present invention, the shell further comprises a cationic polymer. Cationic polymers are known to improve the deposition and rinse resistance of microcapsules on various substrates, such as fabrics, skin, and hair. On the other hand, cationic polymers can also act as dispersion aids.

[0032] Cationic polymers can be amphoteric polymers. In the context of this invention, "amphoteric polymer" is understood as a polymer containing both cationic and anionic groups, or the corresponding ionizable groups. Cationic amphoteric polymers contain more cationic groups than anionic groups or groups capable of forming anions, and therefore have a net positive charge.

[0033] The amphoteric polymer may contain 1 to 99 mol-% cationic groups and 1 to 99 mol-% anionic groups or anion-forming groups. In a preferred embodiment of the present invention, the amphoteric polymer contains 2 to 99 mol-%, particularly 30 to 95 mol-%, and more specifically 60 to 90 mol-% cationic groups and 1 to 98 mol-%, particularly 5 to 70 mol-%, and more specifically 10 to 40 mol-% anionic groups or anion-forming groups. The cationic groups in cationic polymers are pH-independent. The cationic groups in cationic polymers can be quaternary ammonium groups.

[0034] Cationic polymers may be derived from at least one monomer having the functionality of a quaternary ammonium compound. In particular, cationic monomers may be selected from the group consisting of tetramethylaminoacrylate ethyl (ADAME), tetramethylaminoethyl methacrylate (MADAME), dimethyldiallylammonium chloride (DADMAC), acrylamidopropyltrimethylammonium chloride (APTAC), and methacrylamidopropyltrimethylammonium chloride (MAPTAC).

[0035] When a cationic polymer contains an anionic group or a group capable of forming an anion, it may further be derived from monomers selected from the group consisting of acrylic monomers including acrylic acid, methacrylic acid, itaconic acid, crotonic acid, maleic acid, and fumaric acid, and strong acid monomers, such as monomers having sulfonic acid groups or phosphonic acid-type functions, such as 2-acrylamido-2-methylpropanesulfonic acid, vinylsulfonic acid, vinylphosphonic acid, allylsulfonic acid, allylphosphonic acid, and styrenesulfonic acid. The acrylic monomers may also be any water-soluble salts of these monomers, where the salt is an alkali metal, alkaline earth metal, or ammonium. The most preferred acrylic monomers are acrylic acid, methacrylic acid, or water-soluble salts thereof.

[0036] Cationic polymers may further be derived from nonionic monomers selected from the group consisting of water-soluble vinyl monomers, more specifically, acrylamide, methacrylamide, N-isopropylacrylamide, N,N-dimethylacrylamide, N-methylolacrylamide, N-vinylformamide, N-vinylacetamide, N-vinylpyridine, and / or N-vinylpyrrolidone.

[0037] Cationic polymers may be amphoteric polymers derived from cationic monomers or monomers capable of forming cations, particularly those containing at least one quaternary ammonium group; anionic monomers or monomers capable of forming anions, particularly those based on acrylic acid, methacrylic acid or their derivatives; and optionally from nonionic monomers. Such polymers provide optimal shell-fitting combinations with good dispersion efficiency, good flow properties, and excellent affinity for the various substrates mentioned above herein.

[0038] In a more specific embodiment, the amphoteric copolymer is a copolymer of acrylic acid or methacrylic acid and acrylamidopropyltrimethylammonium chloride (APTAC) or methacrylamidopropyltrimethylammonium chloride (MAPTAC), as described in example in WO 2016 / 207180 A1 or WO 2016 / 207187 A1. In a more specific embodiment, the amphoteric copolymer is a terpolymer formed from an acrylic acid monomer, a MAPTAC monomer, and an acrylamide monomer.

[0039] In a more preferred embodiment, acrylic acid / MAPTAC copolymers, and more specifically terpolymers, are formed by reacting 1 to 2 molar equivalents of acrylic acid monomer with 4 molar equivalents of MAPTAC monomer, more specifically 1 molar equivalent of acrylic acid monomer with 4 molar equivalents of MAPTAC monomer (e.g., Floset CAPS 371L), and even more specifically 1.6 molar equivalents of acrylic acid monomer with 4 molar equivalents of MAPTAC monomer. In the context of the present invention, Floset CAPS 371L is a preferred cationic polymer, but it can also be replaced by any other acrylic acid / MAPTAC copolymer described in the preceding paragraph. Another preferred cationic polymer based on MAPTAC / acrylamide is Salcare SC60, commercialized by BASF. In embodiments of the present invention, the copolymer has a molecular weight of at least 100,000 g / mol, and more specifically at least 500,000 g / mol.

[0040] Polymers with low molecular weight do not provide the desired performance, while those with high molecular weight increase the viscosity of both emulsions and microcapsule dispersions too much. The weight ratio of the amphoteric polymer to the core is between 0.04 and 0.20, preferably between 0.07 and 0.15, and more preferably between 0.8 and 0.12. Amphoteric polymers can be prepared using polymerization techniques well known to those skilled in the art. These known polymerization techniques include solution polymerization, gel polymerization, precipitation polymerization, inverted-phase emulsion polymerization, aqueous emulsion polymerization, suspension polymerization, and micelle polymerization.

[0041] Preferably, the weight ratio between the portion of the polyurea resin derived from chitosan and / or chitosan, and the core, is 0.002 and 0.01, preferably 0.004 and 0.008, more preferably 0.006 and 0.007. The level of chitosan is limited by its solubility under the conditions prevailing during microencapsulation. If the level of chitosan is too high, then a portion of this polymer will precipitate in the microcapsule slurry. Conversely, if the level of chitosan is too low, then the desired benefit will be absent.

[0042] Chitosan may have an average molecular weight of 5,000 to 1,000,000 g / mol, preferably 7,500 to 500,000 g / mol, and more preferably 10,000 to 250,000 g / mol. If the molecular weight of chitosan is too high, the microcapsules may aggregate. If the molecular weight of chitosan is too low, the deposition and adhesion of both microcapsules on the keratin may be insufficient. Chitosan may have an average degree of deacetylation higher than 60%, preferably higher than 70%, and more preferably higher than 80%. Chitosan with such a high degree of deacetylation is more soluble than chitosan with a low degree of acetylation, and is therefore more suitable for the purposes of the present invention.

[0043] In the context of this invention, the source of chitosan may be selected from crustaceans (i.e., shrimp chitosan) or fungi (i.e., mushroom chitosan). The use of mushroom chitosan has the advantage that it may result in microcapsules that are entirely of non-animal origin, or in other words, vegan. Some consumers tend to prefer materials that are entirely of non-animal origin. The beneficial agent may be selected from the group consisting of at least one fragrance component and at least one cosmetic component.

[0044] At least one flavor component is selected from the group consisting of: ADOXAL TM (2,6,10-Trimethylundec-9-enal); AGRUMEX TM (Hexyl 2-(tert-butyl)cycloacetate); ALDEHYDE C 10 DECYLIC (decanal); ALDEHYDE C 11 MOA (2-methyldecanal); ALDEHYDE C 11 UNDECYLENIC (undec-10-enal); ALDEHYDE C 110 UNDECYLIC (undecanal); ALDEHYDE C 12 LAURIC (dodecanal); ALDEHYDE C 12 MNA PURE (2-methylundecanal); ALDEHYDE ISO C 11 ((E)-undec-9-enal); ALDEHYDE MANDARINE 10% / TEC ((E)-dodec-2-enal);ALLYL AMYL GLYCOLATE (allyl 2-(isopentyl oxy)acetate);ALLYL CYCLOHEXYL PROPIONATE (allyl 3-cyclohexylpropanoate);ALLYL OENANTHATE (allyl heptanoate); AMBER CORE TM (1-((2-(tert-Butyl)cyclohexyl)oxy)butan-2-ol); AMBERMAX TM (1,3,4,5,6,7-Hexahydro-beta,1,1,5,5-pentamethyl-2H-2,4a-methanonaphthalen-8-ethanol); AMYL SALICYLATE (pentyl 2-hydroxybenzoate); APHERMATE (1-(3,3-dimethylcyclohexyl)ethyl formate);

[0045] BELAMBRE TM ((1R,2S,4R)-2’-Isopropyl-1,7,7-trimethylspiro[bicylco[2.2.1]heptane-2,4’-[1,3]dioxane]); BIGARYL (8-(sec-butyl)-5,6,7,8-tetrahydroquinoline); BOISAMBRENE FORTE TM ((Ethoxymethoxy)cyclododecane); BOISIRISTM ((1S,2R,5R)-2-ethoxy-2,6,6-trimethyl-9-methylenebicyclo[3.3.1]nonane);BORNYL ACETATE((2S,4S)-1,7,7-trimethylbicyclo[2.2.1]heptane-2-ylacetate);BUTYL BUTYRO LACTATE(1-butoxy-1-oxopropane-2-ylbutyrate);BUTYL CYCLOHEXYL ACETATE PARA(4-(tert-butyl)cycloacetate hexyl);

[0046] CARYOPHYLLENE((Z)-4,11,11-trimethyl-8-methylenebicyclo[7.2.0]undeca-4-ene); CASHMERAN TM (1,1,2,3,3-pentamethyl-2,3,6,7-tetrahydro-1H-idene-4(5H)-one); CASSYRANE TM (5-tert-butyl-2-methyl-5-propyl-2H-furan); CITRAL((E)-3,7-dimethylocta-2,6-dienal); CITRAL LEMAROME TM N((E)-3,7-dimethylocta-2,6-dienal); CITRATHAL TM R((Z)-1,1-diethoxy-3,7-dimethylocta-2,6-diene);CITRONELLAL(3,7-dimethylocta-6-enal);CITRONELLOL(3,7-dimethylocta-6-en-1-ol);CITRONELLYL ACETATE(3,7-dimethylocta-6-en-1-yl acetate);CITRONELLYL FORMATE(3,7-dimethylocta-6-en-1-yl formate);CITRONELLYL NITRILE(3,7-dimethylocta-6-ennitrile);CITRONELLYL PROPIONATE(3,7-dimethylocta-6-en-1-ylpropionate);CLONAL(dodecanenitrile);CORANOL(4-cyclohexyl-2-methylbutan-2-ol);COSMONE TM((Z)-3-methylcyclotetradeca-5-enone);CYCLAMEN ALDEHYDE(3-(4-isopropylphenyl)-2-methylpropanal);CYCLOGALBANATE(allyl 2-(cyclohexyloxy)acetate);CYCLOHEXYL SALICYLATE(cyclohexyl 2-hydroxybenzoate);CYCLOMYRAL(8,8-dimethyl-1,2,3,4,5,6,7,8-octahydronaphthalene-2-carbaldehyde);

[0047] DAMASCENONE ((E)-1-(2,6,6-trimethylcyclohexa-1,3-dien-1-yl)buta-2-en-1-one); DAMASCONE ALPHA ((E)-1-(2,6,6-trimethylcyclohexa-2-en-1-yl)buta-2-en-1-one); DAMASCONE DELTA ((E)-1-(2,6,6-trimethylcyclohexa-3-en-1-yl)buta-2-en-1-one); DECENAL-4-TRANS ((E)-deca-4-enal); DELPHONE (2-pentylcyclopentanone); DIHYDRO ANETHOLE (1-(1-(3,3-dimethylcyclohexyl)ethyl)3-ethyl ester of propanediate); DIHYDRO JASMONE (3-methyl-2-pentylcyclopenta-2-enone); DIHYDRO BENZYL CARBINOL (2-methyl-1-phenylpropane-2-ol); DIMETHYL BENZYL CARBINYL ACETATE (2-methyl-1-phenylpropane-2-yl acetate); DIMETHYL BENZYL CARBINYL BUTYLATE (2-methyl-1-phenylpropane-2-yl butyrate); DIMETHYL OCTENONE (4,7-dimethylocta-6-en-3-one); DIMETOL (2,6-dimethylheptan-2-ol); DIPENTENE (1-methyl-4-(propa-1-en-2-yl)cyclohexa-1-ene); DUPICAL TM ((E)-4-((3aS,7aS)-hexahydro-1H-4,7-methanoindene-5(6H)-ylidene)butanal);

[0048] EBANOL TM ((E)-3-methyl-5-(2,2,3-trimethylcyclopenta-3-en-1-yl)penta-4-en-2-ol); ETHYL CAPROATE (ethylhexanoate); ETHYL CAPRYLATE (ethyloctanoate); ETHYL LINALOOL ((E)-3,7-dimethylnonano-1,6-dien-3-ol); ETHYL LINALYL ACETATE ((Z)-3,7-dimethylnonano-1,6-dien-3-yl acetate); ETHYL OENANTHATE (ethylheptanoate); ETHYL SAFRANATE (ethyl 2,6,6-trimethylcyclohexa-1,3-dien-1-carboxylate); EUCALYPTOL ((1s,4s)-1,3,3-trimethyl-2-oxabicyclo[2.2.2]octane);

[0049] FENCHYL ACETATE ((2S)-1,3,3-trimethylbicyclo[2.2.1]heptan-2-yl acetate); FENCHYL ALCOHOL ((1S,2R,4R)-1,3,3-trimethylbicyclo[2.2.1]heptan-2-ol); FIXOLIDE TM (1-(3,5,5,6,8,8-Hexamethyl-5,6,7,8-Tetrahydronaphthalene-2-yl)Ethanone); FLORALOZONE TM (3-(4-ethylphenyl)-2,2-dimethylpropanal); FLORHYDRAL (3-(3-isopropylphenyl)butanal); FLOROCYCLENE TM ((3aR,6S,7aS)-3a,4,5,6,7,7a-Hexahydro-1H-4,7-methanoindene-6-ylpropionate);FLOROPAL TM (2,4,6-trimethyl-4-phenyl-1,3-dioxane); FRESKOMENTHE TM (2-(sec-butyl)cyclohexanone); FRUITATE((3aS,4S,7R,7aS)-ethyloctahydro-1H-4,7-methanoindene-3a-carboxylate); FRUTONILE(2-methyldecanonitrile);

[0050] GALBANONE TM PURE(1-(3,3-dimethylcyclohexa-1-en-1-yl)penta-4-en-1-one); GARDOCYCLENE TM ((3aR,6S,7aS)-3a,4,5,6,7,7a-Hexahydro-1H-4,7-methanoindene-6-ylisobutyrate);GERANIOL((E)-3,7-dimethylocta-2,6-dien-1-ol);GERANYL ACETATE SYNTHETIC((E)-3,7-dimethylocta-2,6-dien-1-ylacetate);GERANYL ISOBUTYRATE((E)-3,7-dimethylocta-2,6-dien-1-ylisobutyrate);GIVESCONE TM (Ethyl 2-ethyl-6,6-dimethylcyclohexa-2-enecarboxylate);

[0051] HABANOLIDE TM ((E)-Oxacyclohexadeca-12-en-2-one); HEDIONE TM (Methyl 3-oxo-2-pentylcyclopentane acetate); HERBANATE TM ((2S)-Ethyl 3-isopropylbicyclo[2.2.1]hepta-5-en-2-carboxylate); HEXENYL-3-CIS BUTYRATE ((Z)-Hexa-3-en-1-ylbutyrate); HEXYL CINNAMIC ALDEHYDE ((E)-2-benzylidene octanal); HEXYL ISOBUTYRATE (Hexyl isobutyrate); HEXYL SALICYLATE (Hexyl 2-hydroxybenzoate);

[0052] INDOFLOR TM(4,4a,5,9b-tetrahydroindeno[1,2-d][1,3]dioxin); IONONE BETA((E)-4-(2,6,6-trimethylcyclohexa-1-en-1-yl)buta-3-en-2-one); IRISONE ALPHA ((E)-4-(2,6,6-trimethylcyclohexa-2-en-1-yl)buta-3-en-2-one); IRONE ALPHA((E)-4-(2,5,6,6-tetramethylcyclohexa-2-en-1-yl)buta-3-en-2-one); ISO E SUPER TM (1-(2,3,8,8-tetramethyl-1,2,3,4,5,6,7,8-octahydronaphthalene-2-yl)ethanone); ISOCYCLOCITRAL (2,4,6-trimethylcyclohexa-3-encarbaldehyde); ISONONYL ACETATE (3,5,5-trimethylhexyl acetate); ISOPROPYL METHYL-2-BUTYRATE (isopropyl 2-methylbutanoate); ISORALDEINE TM 70((E)-3-methyl-4-(2,6,6-trimethylcyclohexa-2-en-1-yl)buta-3-en-2-one);

[0053] JASMACYCLENE TM ((3aR,6S,7aS)-3a,4,5,6,7,7a-Hexahydro-1H-4,7-methanoinden-6-ylacetate);JASMONE CIS((Z)-3-methyl-2-(penta-2-en-1-yl)cyclopenta-2-enone);KARANAL TM (5-(sec-butyl)-2-(2,4-dimethylcyclohexa-3-en-1-yl)-5-methyl-1,3-dioxane); KOAVONE((Z)-3,4,5,6,6-pentamethylhepta-3-en-2-one);

[0054] LEAF ACETAL((Z)-1-(1-ethoxyethoxy)hexa-3-ene); LEMONILE TM ((2E,6Z)-3,7-dimethylnona-2,6-diennitrile); LIFFAROME TMGIV((Z)-Hexa-3-en-1-ylmethylcarbonate); LILIAL TM (3-(4-(tert-butyl)phenyl)-2-methylpropanal); LINALOOL (3,7-dimethylocta-1,6-dien-3-ol); LINALYL ACETATE (3,7-dimethylocta-1,6-dien-3-yl acetate);

[0055] MAHONIAL TM ((4E)-9-hydroxy-5,9-dimethyl-4-decaenal); MALTYL ISOBUTYRATE (2-methyl-4-oxo-4H-pyran-3-ylisobutyrate); MANZANATE (ethyl 2-methylpentanoate); MELONAL TM (2,6-dimethylhepta-5-enal); MENTHOL (2-isopropyl-5-methylcyclohexanol); MENTHONE (2-isopropyl-5-methylcyclohexanone); METHYL CEDRYL KETONE (1-((1S,8aS)-1,4,4,6-tetramethyl-2,3,3a,4,5,8-hexahydro-1H-5,8a-methanoazulene-7-yl)ethanone); METYL NONYL KETONE EXTRA (undecane-2-one); METHYL OCTYNE CARBONATE (methylnonano-2-inoate); METHYL PAMPLEMOUSSE (6,6-dimethoxy-2,5,5-trimethylhexa-2-ene); MYRALDENE (4-(4-methylpenta-3-en-1-yl)cyclohexa-3-encarbaldehyde);

[0056] NECTARYL(2-(2-(4-methylcyclohexa-3-en-1-yl)propyl)cyclopentanone); NEOBERGAMATE TM FORTE (2-methyl-6-methyleneocta-7-ene-2-ylacetate); NEOFOLIONE TM ((E)-methylnona-2-enoate); NEROLIDYLE TM((Z)-3,7,11-trimethyldodeca-1,6,10-triene-3-ylacetate);NERYL ACETATE HC((Z)-3,7-dimethylocta-2,6-diene-1-ylacetate);NONADYL(6,8-dimethylnonan-2-ol);NONENAL-6-CIS((Z)-nonan-6-enal);NYMPHEAL TM (3-(4-isobutyl-2-methylphenyl)propanal); or IVONE TM (4-(tert-pentyl)cyclohexanone);

[0057] PARADISAMIDE TM (2-ethyl-N-methyl-N-(m-tolyl)butanamide); PELARGENE (2-methyl-4-methylene-6-phenyltetrahydro-2H-pyran); PEONILE TM (2-Cyclohexylidene-2-phenylacetonitrile); PETALIA TM (2-Cyclohexylidene-2-(o-Tolyl)acetonitrile); PIVAROSE TM (2,2-dimethyl-2-phenylethylpropanoate); PRECYCLEMONE TM B(1-methyl-4-(4-methylpenta-3-en-1-yl)cyclohexa-3-encarbaldehyde); PYRALONE TM (6-(sec-butyl)quinoline);

[0058] RADJANOL TM SUPER((E)-2-ethyl-4-(2,2,3-trimethylcyclopenta-3-en-1-yl)buta-2-en-1-ol);RASPBERRY KETONE(N112)(4-(4-hydroxyphenyl)butan-2-one);RHUBAFURANE TM (2,2,5-trimethyl-5-pentylcyclopentanone); ROSACETOL (2,2,2-trichloro-1-phenylethyl acetate); ROSALVA (deca-9-en-1-ol); ROSYFOLIA ((1-methyl-2-(5-methylhexa-4-en-2-yl)cyclopropyl)-methanol); ROSYRANETM SUPER(4-methylene-2-phenyltetrahydro-2H-pyran);

[0059] SERENOLIDE(2-(1-(3,3-dimethylcyclohexyl)ethoxy)-2-methylpropylcyclopropanecarboxylate); SILVIAL TM (3-(4-isobutylphenyl)-2-methylpropanal); SPIROGALBANONE TM (1-(Spiro[4.5]deca-6-en-7-yl)penta-4-en-1-on);STEMONE TM ((E)-5-methylheptan-3-oneoxime); SUPER MUGUET TM ((E)-6-ethyl-3-methylocta-6-en-1-ol); SYLKOLIDE TM ((E)-2-((3,5-dimethylhexa-3-en-2-yl)oxy)-2-methylpropylcyclopropanecarboxylate);

[0060] TERPINENE GAMMA (1-methyl-4-propane-2-ylcyclohexa-1,4-diene); TERPINOLENE (1-methyl-4-(propane-2-ylidene)cyclohexa-1-ene); TERPINYL ACETATE (2-(4-methylcyclohexa-3-en-1-yl)propane-2-yl acetate); TETRAHYDRO LINALOOL (3,7-dimethyloctan-3-ol); TETRAHYDRO MYRCENOL (2,6-dimethyloctan-2-ol); THIBETOLIDE (oxacyclohexadecane-2-one); TRIDECENE-2-NITRILE ((E)-trideca-2-ennitrile);

[0061] UNDECAVERTOL ((E)-4-methyldeca-3-en-5-ol); VELOUTONE TM (2,2,5-trimethyl-5-pentylcyclopentanone); VIRIDINE TM ((2,2-dimethoxyethyl)benzene); ZINARINE TM(2-(2,4-dimethylcyclohexyl)pyridine); and mixtures thereof.

[0062] A comprehensive list of fragrance components that may be encapsulated according to the present invention can be found in the fragrance literature, for example, “Perfume & Flavor Chemicals”, S. Arctander, Allured Publishing, 2000. At least one beneficial agent may also be a cosmetic component. Preferably, the cosmetic component has a calculated octanol / water partition coefficient (ClogP) of 1.5 or higher, more preferably 3 or higher. Alternatively, the ClogP of the cosmetic component is preferably between 2 and 7.

[0063] Specifically, useful cosmetic ingredients may be selected from the group consisting of emollients, smoothing surfactants, hydrating surfactants, soothing and relaxing surfactants, decorative surfactants, anti-aging surfactants, exfoliating surfactants, remodeling surfactants, skin leveling surfactants, preservatives, antioxidant surfactants, antibacterial or bacteriostatic surfactants, cleansing surfactants, lubricating surfactants, structuring surfactants, hair conditioning surfactants, whitening surfactants, texturizing surfactants, softening surfactants, anti-dandruff surfactants, and exfoliating surfactants.

[0064] Specifically, useful cosmetic ingredients are not limited to these, but include hydrophobic polymers such as alkyldimethylsiloxane, polymethylsilsesquioxane, polyethylene, polyisobutylene, styrene-ethylene-styrene and styrene-butylene-styrene block copolymers, mineral oils such as hydrogenated isoparaffin, silicone oils, vegetable oils such as argan oil, jojoba oil, and aloe vera oil, fatty acids and fatty alcohols and their esters, glycolipids, phospholipids, and sphingolipids. This includes substances such as ceramides, sterols and steroids, terpenes, sesquiterpenes, triterpenes and their derivatives, and essential oils such as arnica oil, artemisia oil, bark oil, birch leaf oil, calendula oil, cinnamon oil, echinacea oil, eucalyptus oil, ginseng oil, jujube oil, sunflower oil, jasmine oil, lavender oil, lotus seed oil, perilla oil, rosemary oil, sandalwood oil, tea tree oil, thyme oil, valerian oil, absinthe oil, ylang-ylang oil, and yucca oil.

[0065] Core-shell microcapsules according to the present invention generally have a volume-average size (d50) of 1 to 100 μm, preferably 5 to 50 μm, and more preferably 10 to 20 μm. The volume-average size of dispersed particles, such as microcapsules, may be obtained by light scattering measurements according to methods known to those skilled in the art.

[0066] Further aspects of the present invention relate to encapsulated compositions, and in particular, to methods for preparing the encapsulated compositions described above herein. The method consists of the following steps: a) To provide a core composition comprising at least one trifunctional isocyanate, optionally a water-dispersible polyisocyanate, and at least one beneficial agent; b) Mixing the core composition with water and optionally with a cationic copolymer; c) Emulsifying the mixture obtained in b) in order to obtain droplets of the core composition having a volume average size of 1 to 100 μm, preferably 5 to 50 μm, and more preferably 10 to 20 μm; d) Add at least one polyfunctional amine other than chitosan, while preferably maintaining the mixture obtained in c) under stirring; e) The mixture obtained in d) is gradually heated to a temperature of 60-95°C, preferably 80-90°C, preferably over a period of 2-4 hours, for example, 3 ± 0.5 hours; f) Add the mixture obtained in step e) over a period of time, preferably over a period of 1 to 5 hours, for example, 2 ± 0.5 hours, or 4.5 ± 0.5 hours, while maintaining the mixture at the temperature applied in step e); g) To obtain a microcapsule slurry, the mixture obtained in f) is cooled to room temperature. Includes.

[0067] The weight of the trifunctional isocyanate used in step a) relative to the weight of the core composition provided in step a) is between 8 and 20 wt.-%; preferably between 9 and 16 wt.-%; more preferably between 10 and 12 wt.-%.

[0068] The oil-in-water emulsion has the advantage of providing multiple droplets that can be used as templates for shell formation, where the shell is constructed around each of these droplets. In addition, the droplet size distribution may be controlled in the emulsion by controlling the emulsification conditions, such as the stirring speed and the shape of the stirrer. As a result, multiple microcapsules with a controlled average size and size distribution are obtained, where the oil phase is encapsulated and thereby forms the core of the microcapsule. In a specific embodiment of the present invention, the mixture formed in step b) may be left to stand without stirring until the core composition and the aqueous phase separate.

[0069] The weight of the water-dispersible polyisocyanate optionally used in step a) relative to the weight of the core composition provided in step a) may be between 0.1 and 20 wt.-%, preferably between 0.5 and 10 wt.-%, and more preferably between 1 and 5 wt.-%. The weight of at least one non-chitosan polyfunctional amine used in step d) relative to the weight of the mixture obtained in step f) may be between 0.1 and 2 wt.-%, preferably between 0.25 and 1 wt.-%, and more preferably between 0.4 and 0.8 wt.-%.

[0070] The weight of the cationic copolymer optionally used in step b) relative to the weight of the mixture obtained in step f) may be between 2 and 10 wt.-%, preferably between 2.5 and 7.5 wt.-%, and more preferably between 3 and 5 wt.-%. The weight of the chitosan used in step f) relative to the weight of the mixture obtained in step f) may be between 0.06 and 0.3 wt.-%, preferably between 0.12 and 0.24 wt.-%, and more preferably between 0.18 and 0.21 wt.-%.

[0071] The appropriate stirring speed and shape of the mixer can be selected to obtain the desired average droplet size and droplet size distribution. In the method according to the present invention, a 1-liter tank may be used that is equipped with a cross-beam stirrer with a pitched beam, such as a turbine or a Mig stirrer, and has a stirrer diameter relative to a reactor diameter of 0.6 to 0.8. Microcapsules having a volume average size of 30 microns or less, more specifically 20 microns or less, are formed in such a reactor at a stirring speed of about 100 to about 1200 rpm, more specifically about 600 to 1000 rpm. Preferably, the Mig stirrer is used while operating at a speed of 850 + / - 50 rpm. However, as those skilled in the art will know, such stirring conditions may vary depending on the reactor size and batch size, the exact shape of the stirrer, and the ratio of the stirrer diameter to the reactor diameter. For example, for a Mig stirrer with a stirrer diameter ratio of 0.5 to 0.9 to a reactor and a slurry volume ranging from 0.5 to 8 tons, the preferred stirring speed in the context of the present invention is 150 rpm to 50 rpm.

[0072] After the formation of microcapsules, the encapsulated composition is usually permitted to be cooled to room temperature (cf. above step g). Before, during, or after cooling, the encapsulated composition may be further processed. Further processing may include treatment of the composition with antimicrobial preservatives, which are well known in the art. Further processing may also include the addition of suspension aids, such as hydrophilic colloidal suspension aids, to aid in the stable physical dispersion of the microcapsules and prevent any creaming or coalescence. Preferred suspension aids are hydroxyethylcellulose, for example, Natrosol 250HX (ex Ashland). Any additional adjuvants conventional in the art may also be added during further processing.

[0073] A further aspect of the present invention relates to encapsulated compositions that can be obtained by the methods described above in this specification. Another aspect of the present invention relates to the use of encapsulated compositions, as described herein, for enhancing the performance of beneficial agents in consumer products. The present invention also relates to consumer products comprising encapsulated compositions as described above herein. Consumer products are preferably selected from the group consisting of hair care products, in particular shampoos and hair conditioners. On the other hand, consumer products may also be other types of personal care products, such as soaps, body washes, shower gels, or skincare products.

[0074] As used herein, “consumer product” means an article intended to be used or consumed in the form in which it is sold, and not intended to be subsequently manufactured or modified for commercial purposes. The encapsulated compositions according to the present invention are particularly useful when employed as fragrance delivery vehicles in consumer products that require sufficient adhesion of microcapsules to the substrate to which they are applied in order to deliver optimal fragrance benefits. Such consumer products include, among other things, hair shampoos and conditioners, but also textile treatment products, such as laundry detergents and conditioners.

[0075] Consumer products according to the present invention may contain 0.01 to 5 wt.-%, preferably 0.05 to 2.5 wt.-%, and more preferably 0.1 to 1 wt.-%, of microcapsules as described above, based on the total weight of the consumer product. Consumer products according to the present invention may contain 0.00001 to 0.005 wt.-%, more specifically 0.00005 to 0.001 wt.-%, and even more specifically 0.00008 to 0.0005 wt.-%, of free chitosan based on the total weight of the consumer product. The present invention also relates to a method for enhancing the performance of beneficial agents in consumer products by adding encapsulated compositions according to the present invention.

[0076] The specific features and further advantages of the present invention will become apparent from the following examples. Example 1 - Preparation of polyurea microcapsules according to the present invention In Example 1.1, microcapsules were obtained by performing the following steps: - The core composition is prepared by mixing 1 g of Bayhydur XP 2547 (ex Covestro), 4 g of Takenate D110N (ex Mitsui), and 30 g of fragrance composition (ex Givaudan) in a reactor equipped with a stirrer; - Stir the core composition at 600 rpm for 10 minutes; - Add 40 g of water to the core composition, then add 3 g of poly(methacrylamidopropyltrimethylammonium chloride-co-acrylic acid) copolymer having 71 mol-% methacrylamidopropyltrimethylammonium chloride and 29 mol-% acrylic acid, prepared according to WO 2016 / 207187 A1 (Example 1);

[0077] - To obtain an emulsion with a volume-average core composition droplet size (d50) of 10 ± 2 μm, the resulting mixture is stirred at 1100 rpm for 30 minutes; - Add 0.6g of Lupasol G100 (ex BASF); - Heat the mixture at a rate of 0.3°C / min; - After 120 minutes, add a mixture of 0.2 g of chitosan with an average molecular weight of 200,000 g / mol (from shrimp, ex Acros), 0.4 g of 30 vol.-% acetic acid in water, and 10 g of water;

[0078] - Once the temperature reaches 85°C, maintain the mixture at this temperature for a further 120 minutes: - Add 4 g of 20% ammonia solution in water and maintain the mixture for a further 35 minutes; - To obtain a microcapsule slurry, cool the resulting mixture to 25°C within 60 minutes.

[0079] The solid content of the slurry was measured using a thermobalance operated at 120°C. The solid content, expressed as a weight percentage of the initial slurry deposited on the balance, was determined when the drying-induced weight change rate decreased to less than 0.1% / min. The ratio of the measured solid content to the thermal solid content, calculated based on the weight of the fragrance and related encapsulating material, was determined as a measure of the encapsulation yield, expressed in wt.-%. The solid content of the obtained slurry was 37 wt.-%, the volume-average capsule size (d50) was 10 ± 1 μm, and the encapsulation efficiency was 100%.

[0080] In Example 1.1, the weight of the trifunctional isocyanate used relative to the weight of the provided core composition was 11 wt.-% (weight ratio of trifunctional isocyanate to fragrance: 0.13). In Example 1.2, the weight of the trifunctional isocyanate used relative to the weight of the provided core composition was 14 wt.-%, but microcapsules were obtained using the same process as in Example 1.1 (weight ratio of trifunctional isocyanate to fragrance: 0.17). In Example 1.3, the weight of the trifunctional isocyanate used relative to the weight of the provided core composition was 19 wt.-%, but microcapsules were obtained using the same process as in Example 1.1 (weight ratio of trifunctional isocyanate to fragrance: 0.25).

[0081] In Example 1.4, mushroom chitosan l (ex Kionutrime) with a molecular weight of 85,000 g / mo was used, but microcapsules were obtained using the same process as in Example 1.1. In Example 1.5, mushroom chitosan (ex Kionutrime) with a molecular weight of 15,000 g / mol was used, but microcapsules were obtained using the same process as in Example 1.1.

[0082] Table 1: Variations of polyisocyanate and chitosan types [Table 1]

[0083] Example 2 - Comparative Example A series of microcapsules was obtained by varying the weight ratio of Takenate D110N to fragrance oil and the weight ratio of chitosan to fragrance oil according to the table and carrying out the process as described in Example 1.1. In Examples 2.1 and 2.2, Takenate D110N was replaced by Desmodur W (methylenebis(4-cyclohexyl isocyanate)).

[0084] Table 2: Variations in the amounts of polyisocyanate and chitosan [Table 2] Reference samples 2.1 and 2.2 exhibited 100% fragrance leakage in the shampoo base and were unstable over storage.

[0085] Example 3 - Comparison of Olfactory Performance The olfactory performance of the microcapsules was assessed by four panelists who rated the odor intensity on a scale from 1 to 5 (1 = barely perceptible, 2 = weak, 3 = medium, 4 = strong, and 5 = very strong). The samples were evaluated in unscented shampoo and hair care conditioner. The aforementioned slurry was added to these bases under gentle stirring using a paddle mixer so that the slurry level was 0.6 wt.-% of the total weight of each base.

[0086] In the case of shampoo, 20 wt.-% shampoo was applied to hair samples that had already been moistened with the same weight of water, based on the total weight of the hair samples. The dry weight of each sample was approximately 12 g. In the case of hair conditioner, the sample was first washed with a scented shampoo and then rinsed with water. Next, 10 wt.-% of the conditioner was applied immediately after washing with the shampoo, based on the total weight of the sample.

[0087] For both the shampoo and hair conditioner, samples were subjected to a 20-second massage, followed by a 30-second rinse with tap water at 37°C at a flow rate of 3.2 l / min, without touching the samples by hand. Samples were handled carefully during this evaluation to minimize the risk of mechanically destroying the microcapsules. Olfactory evaluations were conducted pre-rub and post-rub after the samples had been dried at room temperature for 24 hours (cold-air dried). This evaluation was performed by gently combing a portion of each sample five times.

[0088] For evaluation including hair drying (heat hair drying), hair samples were left in the air for 15 minutes. Then, they were operated at an internal temperature of 180°C, and 0.016 m 3 A standard hair dryer providing a volumetric airflow of 1 / s was positioned 5 cm away from a hair sample, and the airflow was applied for 5 minutes, moving the airflow above and below the sample during these 5 minutes. The temperature on the hair was approximately 40-45°C. The results are shown in Tables 3 and 4.

[0089] Table 3: Olfactory performance on hair samples - for shampoos [Table 3]

[0090] Table 4: Olfactory performance of freshly prepared microcapsules on hair samples and expired microcapsules on hair samples - in the case of hair conditioner. [Table 4]

[0091] These results demonstrate the positive effect of combining Takenate D110N with chitosan on maintaining the performance of microcapsules, even after drying hair with a hairdryer and after storage in shampoo and conditioner. .

Claims

1. 1. An encapsulated composition comprising at least one core-shell microcapsule, wherein the at least one core-shell microcapsule comprises a core comprising at least one benefit agent, and a shell surrounding the core, wherein the shell comprises a polyurea resin formed by the reaction of at least one trifunctional isocyanate with at least one polyfunctional amine that is not chitosan, wherein the at least one trifunctional isocyanate is an adduct of an aliphatic triol and at least one araliphatic diisocyanate, wherein the weight ratio between the portion of the polyurea resin derived from the trifunctional isocyanate and the core is between 0.09 and 0.30, preferably between 0.10 and 0.20, more preferably between 0.11 and 0.18, and wherein the shell further comprises chitosan.

2. 2. The composition of claim 1, wherein the aliphatic triol is selected from the group consisting of 2-ethylpropane-1,2,3-triol and 2-ethyl-2-(hydroxymethyl)propane-1,3-diol, preferably 2-ethylpropane-1,2,3-triol.

3. 3. The composition of claim 1 or 2, wherein the at least one araliphatic isocyanate is selected from the group consisting of 1,2-bis(isocyanatomethyl)benzene, 1,3-bis(isocyanatomethyl)benzene, 1,4-bis(isocyanatomethyl)benzene, 1-isocyanato-2-(isocyanatomethyl)benzene, 1-isocyanato-3-(isocyanatomethyl)benzene, and 1-isocyanato-4-(isocyanatomethyl)benzene.

4. 2. The composition of claim 1, wherein the at least one trifunctional isocyanate is an adduct of 2-ethylpropane-1,2,3-triol and 1,3-bis(isocyanatomethyl)benzene.

5. The composition according to any one of claims 1 to 4, wherein the chitosan is deposited on the outer surface of a shell surrounding the core and / or the chitosan is encapsulated in a shell surrounding the core.

6. The composition of claim 5 further comprising free chitosan.

7. 5. The composition of claim 1, wherein the polyurea resin is formed by the reaction of at least one trifunctional isocyanate, at least one polyfunctional amine that is not chitosan, and chitosan.

8. 8. The composition of any one of claims 1 to 7, wherein the polyurea resin is formed by the reaction of at least one trifunctional isocyanate and a water-dispersible polyisocyanate with at least one polyfunctional amine that is not chitosan, and optionally chitosan.

9. The composition according to any one of claims 1 to 8, wherein the water-dispersible polyisocyanate is a water-dispersible polyisocyanate based on hexamethylene diisocyanate.

10. The composition of any one of claims 1 to 9, wherein the non-chitosan polyfunctional amine is poly(ethyleneimine).

11. The composition of any one of claims 1 to 10, wherein the shell further comprises a cationic polymer.

12. 12. The composition according to any one of claims 1 to 11, wherein the weight ratio between the chitosan and / or the portion of the polyurea resin derived from chitosan and the core is 0.002 and 0.01, preferably 0.004 and 0.008, more preferably 0.006 and 0.

007.

13. 13. The composition according to any one of the preceding claims, wherein the chitosan has an average molecular weight of from 5,000 to 1,000,000 g / mol, preferably from 7,500 to 500,000 g / mol, even more preferably from 10,000 to 250,000 g / mol.

14. 14. The composition according to any one of claims 1 to 13, wherein the chitosan has an average degree of deacetylation higher than 60%, more particularly higher than 70%, even more particularly higher than 80%.

15. The composition of any one of claims 1 to 14, wherein the benefit agent is selected from the group consisting of at least one fragrance ingredient and at least one cosmetic ingredient.

16. A method for preparing an encapsulated composition, in particular an encapsulated composition according to any one of claims 1 to 15, comprising the following steps: a) providing a core composition comprising at least one trifunctional isocyanate, optionally a water-dispersible polyisocyanate, and at least one benefit agent; b) mixing the core composition with water and optionally a cationic copolymer; c) emulsifying the mixture obtained in b) to obtain droplets of the core composition having a volume average size of 1 to 100 μm, preferably 5 to 50 μm, even more preferably 10 to 20 μm; d) adding at least one polyfunctional amine which is not chitosan to the mixture obtained in c), preferably while maintaining it under stirring; e) gradually heating the mixture obtained in d) to a temperature of 60-95°C, preferably 80-90°C, preferably over a period of 2-4 hours, e.g., 3±0.5 hours; f) adding the mixture obtained in step e), preferably while maintaining the mixture at the temperature applied in step e), especially over a period of 1 to 5 hours, for example 2±0.5 hours, or 4.5±0.5 hours; g) cooling the mixture obtained in f) to room temperature to obtain a slurry of microcapsules; wherein the weight of the trifunctional isocyanate used in step a) relative to the weight of the core composition provided in step a) is between 8 and 20 wt.-%, preferably between 9 and 16 wt.-%, more preferably between 10 and 12 wt.-%; The method comprising:

17. 17. The method of claim 16, wherein the mixture formed in step b) is allowed to stand without stirring until the core composition and water separate.

18. 18. An encapsulated composition obtainable by the method of claim 16 or 17.

19. 19. Use of an encapsulated composition according to any one of claims 1 to 15 or claim 18 to enhance the performance of a benefit agent in a consumer product.

20. 19. A consumer product comprising an encapsulated composition according to any one of claims 1 to 15 or claim 18, wherein the consumer product is preferably a hair care product, especially selected from the group consisting of shampoos and hair conditioners.